Phase 1 randomized, parallel and pharmacokinetics study meloxicam and esomeprazole after single and multiple dose administration of AXS-06 in healthy volunteers.

Trial Profile

Phase 1 randomized, parallel and pharmacokinetics study meloxicam and esomeprazole after single and multiple dose administration of AXS-06 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Esomeprazole/meloxicam (Primary) ; Esomeprazole; Meloxicam
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Jul 2017 New trial record
    • 25 Jul 2017 Primary endpoint (time to maximum plasma concentration (Tmax) of meloxicam versus Mobic) has been met, according to an Axsome Therapeutics Media Release.
    • 25 Jul 2017 Results published in anAxsome Therapeutics Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top